Flu treatment and transmission study for children and families
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study tests how well a single-dose flu treatment (baloxavir marboxil) works for children with the flu and whether it stops the flu from spreading to family members. If your child has early flu symptoms and lives with others, participation could help protect your household.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have flu symptoms (like fever, cough) that started less than 48 hours ago and a positive flu test.
- Your child's COVID test (taken in the last 2 days) must be negative.
- Your child cannot have severe flu needing hospital care, a weakened immune system, or a current infection needing antibiotics or antivirals.
- Your child cannot have taken any flu medicine (like Tamiflu) in the last month.
- Your child's household must have at least one other person who agrees to join the study and hasn't had a flu shot in the last 6 months.
- If your child is female and has started her period, she cannot join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of flu prevention medicine (called a monoclonal antibody) given as an injection. It is for people at higher risk of getting the flu, including those with certain health conditions or weakened immune systems.
This study tests an investigational flu medicine (called Suraxavir Marboxil) for children with the flu. The goal is to see if it safely and effectively treats flu symptoms and shortens the illness.
This study tests two flu medicines, oseltamivir and baloxavir marboxil, to see if they can prevent flu in people who are in the hospital and were exposed to someone with the flu. It may help you avoid getting sick while you are in the hospital.
This trial tests whether two flu medicines—baloxavir and oseltamivir—work better to treat influenza in people with weakened immune systems (like transplant or blood cancer patients). It may help reduce severe complications, especially when flu affects the lungs or is at high risk to do so.
This trial tests if taking suraxavir marboxil or oseltamivir can stop the flu from spreading to people sharing a hospital room with a patient who has the flu.
This Phase 2 study compares antiviral medicines in adults who have early, flu-like symptoms and test positive for influenza. It aims to see which antiviral treatment works best and is safe for people treated soon after symptoms start.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.